Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Doublecortin domain-containing protein 2 (DCDC2) is a microtubule-associated protein containing doublecortin domains, which bind to tubulin and enhance microtubule polymerization[1][2][3]. DCDC2 plays a critical role in *neuronal migration* and *cilia-related signaling* in developing neurons and sensory hair cells, influencing both cortical development and auditory function[1]. Mutations and regulatory variants in DCDC2 have been associated with *developmental dyslexia*, likely by affecting cilia-dependent processes in the brain that govern language and reading function[1][2][3]. Although linked to several rare diseases (including autosomal recessive deafness and neonatal sclerosing cholangitis), DCDC2 is best known for its role in neurodevelopment. There is no evidence that DCDC2 functions as a receptor, transporter, or enzyme, and it is not targeted by current pharmaceuticals[1][2][3].
Not applicable—there are no drugs targeting DCDC2 directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Doublecortin domain-containing protein 2 (DCDC2).